PVH
ALBO

Psagot Value Holdings’s Albireo Pharma Inc ALBO Stock Holding History

Psagot Value Holdings’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,800
Closed -$132K – 397
2022
Q3 		$132K Buy
+6,800
New +$141K 0.04% 222
2017
Q3 		– Sell
-2,367
Closed -$49K – 331
2017
Q2 		$49K Hold
2,367
– – ﹤0.01% 265
2017
Q1 		$57K Hold
2,367
– – ﹤0.01% 275
2016
Q4 		$42K Hold
2,367
– – ﹤0.01% 273
2016
Q3 		$31K Hold
2,367
– – ﹤0.01% 276
2016
Q2 		$22K Hold
2,367
– – ﹤0.01% 272
2016
Q1 		$23K Hold
2,367
– – ﹤0.01% 312
2015
Q4 		$24K Hold
2,367
– – ﹤0.01% 325
2015
Q3 		$31K Hold
2,367
– – ﹤0.01% 311
2015
Q2 		$73K Hold
2,367
– – ﹤0.01% 310
2015
Q1 		$84K Buy
+2,367
New +$99.8K ﹤0.01% 288

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Psagot Value Holdings's ALBO Position: Q4 2022 in Review

Psagot Value Holdings sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 6,800 shares — an estimated $132K sold.

Psagot Value Holdings first reported a position in ALBO in Q1 2015 and held it in 11 quarters. The position peaked at $132K in Q3 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Psagot Value Holdings reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Psagot Value Holdings sold 6,800 Albireo Pharma Inc shares in Q4 2022, an estimated $132K.
  • Psagot Value Holdings first reported a position in Albireo Pharma Inc in Q1 2015 and held it in 11 quarters.
  • Psagot Value Holdings's Albireo Pharma Inc position peaked at $132K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on Psagot Value Holdings's 13F filing for Q4 2022, filed 30 Jan 2023.